正电子图像的定量分析在临床肿瘤学中的应用

耿建华; 陈英茂; 耿建华; 陈英茂

[1]

Weber WA, Neverve J, Sklarek J, et al. Imaging of lung cancer with fluorine-18 fluoradeoxyglucose:comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system[J]. Eur J Nucl Med, 1999, 26(4):388-395.

[2]

Tatsumi M, Yutani K, Watanabe Y, et al. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer:comparison with FDG PET[J]. J Nucl Med, 1999, 40(4):566-573.

[3]

Weber W, Young C, Abdel-Dayem HM, et al. Assessment of pulmonary lesions with ¹⁸F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras[J]. J Nucl Med, 1999, 40(4):574-578.

[4]

Yutani K, Tatsumi M, Eiichi S, et al. comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detecting of breast cancer and axillary lymph node metastasis[J]. J Nucl Med,1999, 40(6):1003-1008.

[5]

Aoki J, Watanabe H, Shinozaki T, et al. FDG-PET in differential diagnosis and grading of chondrosarcomas[J]. J Comput Assist Tomogr, 1999, 23(4):603-608.

[6]

Benard F, Sterman D, Smith RJ, et al. Prognostic value of FDG PET imaging in malignant pleural mesothelioma[J]. J Nucl Med, 1999, 40(8):1241-1245.

[7]

Eary JF, O'Sullivan F, Powitan Y, et al. Sarcoma tumor FDG uptake measured by PET and patient outcome:a retrospective analysis[J].EurJ Nucl Med, 2002, 29(9):1149-1154.

[8]

Vansteenkiste JF, Stroobants SG, Dupont PJ, et al. Prognostic importance of the standardized uptake value on ¹⁸F-Fluoro-2-dexoy-glucose-positron emission tomography scan in non-small-cell lung cancer:. An analysis of 125 cases[J]. J Clin Oncol, 1999, 17(10):3201-3206.

[9]

Chen CH, Muzic RF Jr, Nelson AD, et al. Simultaneous recovery of size and radioactivity concentration of small spheroids with PET data[J]. J Nuel Med, 1999, 40(1):118-130.

[10]

Zimny M, Kaiser H J, Wildberger J, et al. Analysis of FDG uptake with hybrid PET using standardised uptake values[J]. Eur J Nucl Med, 2001, 28(5):586-592.

[11]

Wieder HA, Brucher BL, Zimmermann F, et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment[J]. J Clin Oncol,2004, 22(5):900-908.

[12]

Sakarnato H, Nakai Y, Ohashi Y, et al. Monitoring of response to radiotherapy with tluorine-18 deoxyglucose FDG PET of head and neck squamous cell carcinomas[J]. Acta Otolaryngol, 1998,538(suppl):254-260.

[13]

Kitagawa Y, Sadato N, Azuma H, et al. ¹⁸F-FDC. PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms[J]. J Nucl Med, 1999, 40(7):1132-1137.

[14]

Kostakoglu L, Goldsmith SJ. PET in assessment of therapy response in patients with carcinoma of the head and neck and of the esgphagus[J]. J Nucl Med, 2004, 45(1):56-68.

[15]

Huang SC. Anatomy of SUV[J]. Nucl Med Biol, 2000, 27(7):643-646.

[16]

Visvikis D, Cheze-LeRest C, Costa DC, et al. Influence of OSEM and segmented attenuation correction in the calculation of standardized uptake values for[¹⁸FDG PET[J]. Eur J Nucl Med, 2001, 28(9):1326-1335.

[17]

黄建敏,付占立,潘莉萍.¹⁸F-FDG代谢显像标准摄取值的影响因素[J].国外医学·放射医学核医学分册,2004,28(1):3-5.

[18]

Ramos CD, Erdi YE, Gonen M, et al. FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection[J].Eur J Nucl Med, 2001, 28(2):155-164.

[19]

耿建华,陈英茂,陈盛祖.¹⁸F-FDG图像糖代谢定量分析中的输入函数及集总常数[J].国外医学·放射医学核医学分册,2003,27(6):263-266.

[20]

Lerman H, Master U, Grisaru D, et al. Normal and abnormal ¹⁸F-FDG endometrlal and ovarian uptake in pre- and postmenopausal vatients:assessment by PET/CT[J]. J Nucl Med, 2004, 45(2):266-271.

[21]

李林法.¹⁸F-FDG分子符合成像非肿瘤性摄取与对策[J].国外医学·放射医学核医学分册,2002,26(5):205-209.

[22]

Beaulieu S, Kinahan P, Tseng J, et al. SUV varies with time after injection in ¹⁸F-FDG PET of breast cancer:characterization and method to adjust for time differences[J]. J Nucl Med, 2003, 44(7):1044-1050.

[23]

Ishii K, Sakamoto S, Hosaka K, et al. Variation in FDG uptakes in different regions in normal human brain as a function of the time (30and 60 min)after injection of FDG[J]. Ann Nucl Med, 2002, 16(4):299-301.